Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey J Lindeman

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Gastroenterology|April 21, 2009
Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancerAndrew V Biankin, James G Kench, Emily K Colvin, et al.
Nature Medicine|June 24, 2024
Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer: a phase 1 trialToru Mukohara, Yeon Hee Park, David Sommerhalder, et al.
Blood|October 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemiaMeng-Xiao Luo, Tania Tan, Marie Trussart, et al.
Stem Cells (Dayton, Ohio)|December 24, 2016
New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem CellsCarmel M O'Brien, Hun S Chy, Qi Zhou, et al.
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
Cancer Metastasis Reviews|December 28, 2016
Patient-derived xenograft (PDX) models in basic and translational breast cancer researchLacey E Dobrolecki, Susie D Airhart, Denis G Alferez, et al.
Cancer Discovery|December 7, 2018
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast CancerSheau W Lok, James R Whittle, François Vaillant, et al.
Cell Death & Disease|March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumorsChristoph Grohmann, Francesca Walker, Mark Devlin, et al.
The New England Journal of Medicine|August 8, 2014
Breast-cancer risk in families with mutations in PALB2Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, et al.
NPJ Breast Cancer|May 12, 2023
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variantsTaru A Muranen, Anna Morra, Sofia Khan, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Gastroenterology|April 21, 2009
Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancerAndrew V Biankin, James G Kench, Emily K Colvin, et al.
Nature Medicine|June 24, 2024
Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer: a phase 1 trialToru Mukohara, Yeon Hee Park, David Sommerhalder, et al.
Blood|October 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemiaMeng-Xiao Luo, Tania Tan, Marie Trussart, et al.
Stem Cells (Dayton, Ohio)|December 24, 2016
New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem CellsCarmel M O'Brien, Hun S Chy, Qi Zhou, et al.
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
Cancer Metastasis Reviews|December 28, 2016
Patient-derived xenograft (PDX) models in basic and translational breast cancer researchLacey E Dobrolecki, Susie D Airhart, Denis G Alferez, et al.
Cancer Discovery|December 7, 2018
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast CancerSheau W Lok, James R Whittle, François Vaillant, et al.
Cell Death & Disease|March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumorsChristoph Grohmann, Francesca Walker, Mark Devlin, et al.
The New England Journal of Medicine|August 8, 2014
Breast-cancer risk in families with mutations in PALB2Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, et al.
NPJ Breast Cancer|May 12, 2023
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variantsTaru A Muranen, Anna Morra, Sofia Khan, et al.
Pageof 17